Examining the effects of cannabis use in cancer patients during treatment
Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment
This study is looking at how cancer patients use cannabis and cannabinoids to help with symptoms like pain, nausea, and anxiety during their early treatment, so we can better understand what works and what doesn’t for them.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10931487 on NIH RePORTER |
What this research studies
This research investigates how cannabis and cannabinoids (CAC) are used by cancer patients during their initial treatment phases. It aims to understand both the benefits and potential harms of CAC use, particularly in managing symptoms like pain, nausea, and anxiety. The study will follow patients over time to gather data on their experiences and how CAC affects their use of standard treatments. By focusing on community-based healthcare settings, the research seeks to provide valuable insights for both patients and healthcare providers.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are currently undergoing treatment for cancer.
Not a fit: Patients who are not currently receiving cancer treatment or those who do not use cannabis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help clarify the role of cannabis in cancer treatment, leading to better-informed decisions for patients and healthcare providers.
How similar studies have performed: While there is some evidence supporting the benefits of cannabis for certain cancer-related symptoms, this research is addressing significant knowledge gaps and is considered novel in its comprehensive approach.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Potosky, Arnold L — Georgetown University
- Study coordinator: Potosky, Arnold L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.